Effect of BH-HF3.0 on Vasomotor Symptoms (VMS) in Menopausal Women: A De-Centralized, Randomized, Double-Blinded, Placebo-Controlled Clinical Trial

The study aims to explore the effects of a product called Bonafide-HF3.0 on symptoms experienced by women going through menopause, particularly focusing on vasomotor symptoms like hot flashes and night sweats. Menopause often brings about various changes, including mood swings, sleep disturbances, and more. Many women experience these symptoms during menopause, which can significantly affect their quality of life. Current treatments, like hormone replacement therapy, can be effective but may come with risks such as an increased chance of breast cancer. This study targets women aged 40 to 65 who are experiencing menopausal symptoms and seeks to find a safe alternative to hormone therapy using Bonafide-HF3.0, which includes natural ingredients like green tea extract, curcumin, and phycocyanin. Participants in this study will be randomly assigned to receive either Bonafide-HF3.0 or a placebo, meaning they will not know which one they are taking, to ensure unbiased results. The study is designed to compare the effects of the actual treatment against no active treatment. The focus is on observing any changes in the severity and frequency of vasomotor symptoms as well as overall menopausal symptoms. This approach helps determine the effectiveness of Bonafide-HF3.0 in reducing hot flashes and other related symptoms, potentially offering a safer alternative for managing menopause-related discomforts.